1956379-02-4

Basic information

• Product Name: 5,7-dibromo-1H-pyrazolo[4,3-b]pyridine
• CAS NO: 1956379-02-4
• Molecular Weight: 276.918
• Mol File: 1956379-02-4.mol
• Article Data: 6

Chemical Properties

• CAS DataBase Reference: 5,7-dibromo-1H-pyrazolo[4,3-b]pyridine(CAS DataBase Reference)
• NIST Chemistry Reference: 5,7-dibromo-1H-pyrazolo[4,3-b]pyridine(1956379-02-4)
• EPA Substance Registry System: 5,7-dibromo-1H-pyrazolo[4,3-b]pyridine(1956379-02-4)

Safety Data

• Hazardous Substances Data: 1956379-02-4(Hazardous Substances Data)

Upstream product

• 110-46-3 isopentyl nitrite 
• 126325-47-1 3-amino-6-bromo-2-methylpyridine 
• 75-03-6 ethyl iodide 

Relevant articles and documents

COMBINATION TREATMENTS COMPRISING ADMINISTRATION OF 1H-PYRAZOLO[4,3-B]PYRIDINES

The present invention provides 1H-pyrazolo[4,3-b]pyridin-7-amines of formula (I) as PDE1 inhibitors together with a second compound useful in the treatment of a neurodegenerative disorder and their combined use as a medicament, in particular for the treatment of neurodegenerative and/or cognitive disorders.

1H-PYRAZOLO[4,3-B]PYRIDINES AS PDE1 INHIBITORS

The present invention provides 1H-pyrazolo[4,3-b]pyridines of formula (I) as PDE1 inhibitors and their use as a medicament, in particular for the treatment of neurodegenerative disorders and psychiatric disorders.

PYRAZOLO[3,4-B]PYRIDINES AND IMIDAZO[1,5-B]PYRIDAZINES AS PDE1 INHIBITORS

The present invention provides compounds of formula (I) that are PDEl enzyme inhibitors and their use as a medicament, in particular for the treatment of neurodegenerative disorders and psychiatric disorders. The present invention also provides pharmaceutical compositions comprising compounds of the invention and methods of treating disorders using the compounds of the invention.